Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rebecca Kahn

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Vaccine|June 16, 2021
Interpreting vaccine efficacy trial results for infection and transmissionMarc Lipsitch, Rebecca Kahn
Medrxiv : the Preprint Server for Health Sciences|March 3, 2021
Interpreting vaccine efficacy trial results for infection and transmissionMarc Lipsitch, Rebecca Kahn
Nature Medicine|April 29, 2020
Antibody testing will enhance the power and accuracy of COVID-19-prevention trialsMarc Lipsitch, Rebecca Kahn, Michael J Mina
Epidemiology (Cambridge, Mass.)|September 1, 2021
Estimating Vaccine Efficacy Against Transmission via Effect on Viral LoadLee Kennedy-Shaffer, Rebecca Kahn, Marc Lipsitch
Medrxiv : the Preprint Server for Health Sciences|October 24, 2023
Some principles for using epidemiologic study results to parameterize transmission modelsKeya Joshi, Rebecca Kahn, Christopher Boyer, et al.
Medrxiv : the Preprint Server for Health Sciences|March 24, 2021
Examining SARS-CoV-2 Interventions in Residential Colleges Using an Empirical NetworkHali L Hambridge, Rebecca Kahn, Jukka-Pekka Onnela
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 8, 2021
Examining SARS-CoV-2 Interventions in Residential Colleges Using an Empirical NetworkHali L Hambridge, Rebecca Kahn, Jukka-Pekka Onnela
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 11, 2022
Effect of a two-dose vs three-dose vaccine strategy in residential colleges using an empirical proximity networkHali L Hambridge, Rebecca Kahn, Jukka-Pekka Onnela
Clinical Trials (London, England)|January 30, 2018
Impact of stochastically generated heterogeneity in hazard rates on individually randomized vaccine efficacy trialsRebecca Kahn, Matt Hitchings, Steven Bellan, et al.
Journal of Biopharmaceutical Statistics|December 28, 2025
Covariate adjusted dose-response curves with applications to vaccine clinical trialsNong Shang, Stephanie Schrag, Rebecca Kahn, et al.
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Vaccine|June 16, 2021
Interpreting vaccine efficacy trial results for infection and transmissionMarc Lipsitch, Rebecca Kahn
Medrxiv : the Preprint Server for Health Sciences|March 3, 2021
Interpreting vaccine efficacy trial results for infection and transmissionMarc Lipsitch, Rebecca Kahn
Nature Medicine|April 29, 2020
Antibody testing will enhance the power and accuracy of COVID-19-prevention trialsMarc Lipsitch, Rebecca Kahn, Michael J Mina
Epidemiology (Cambridge, Mass.)|September 1, 2021
Estimating Vaccine Efficacy Against Transmission via Effect on Viral LoadLee Kennedy-Shaffer, Rebecca Kahn, Marc Lipsitch
Medrxiv : the Preprint Server for Health Sciences|October 24, 2023
Some principles for using epidemiologic study results to parameterize transmission modelsKeya Joshi, Rebecca Kahn, Christopher Boyer, et al.
Medrxiv : the Preprint Server for Health Sciences|March 24, 2021
Examining SARS-CoV-2 Interventions in Residential Colleges Using an Empirical NetworkHali L Hambridge, Rebecca Kahn, Jukka-Pekka Onnela
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 8, 2021
Examining SARS-CoV-2 Interventions in Residential Colleges Using an Empirical NetworkHali L Hambridge, Rebecca Kahn, Jukka-Pekka Onnela
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 11, 2022
Effect of a two-dose vs three-dose vaccine strategy in residential colleges using an empirical proximity networkHali L Hambridge, Rebecca Kahn, Jukka-Pekka Onnela
Clinical Trials (London, England)|January 30, 2018
Impact of stochastically generated heterogeneity in hazard rates on individually randomized vaccine efficacy trialsRebecca Kahn, Matt Hitchings, Steven Bellan, et al.
Journal of Biopharmaceutical Statistics|December 28, 2025
Covariate adjusted dose-response curves with applications to vaccine clinical trialsNong Shang, Stephanie Schrag, Rebecca Kahn, et al.
Pageof 6